The Fund Grade · free · no account needed

What grade does JSVAX get?

Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.

D

Fundprints Fund Grade · as of 2026-09-01

Janus Henderson Contrarian Fund - T Shares

#306 of 440 graded active funds · blend · large segment peer group

The point · specialist footprint

JSVAX sits mid pack for specialist backing among graded funds.

Bottom 20%

Bottom 40%

● Middle

Top 40%

Top 20%

beat the S&P in 22% of quarters+3.8 pts/qtr better · 43% beat rate

The middle rungs sat between the extremes, and the pattern was monotonic: every step up in specialist backing came with better subsequent results. Not damning, not compelling. The fee decides whether it is worth it.

2,825 graded funds · 2.7 years of filings, measured as they were published · evidence, not advice

3 funds in the same segment carry an A — members see the names and what they charge. See the alternatives →

The grade scores this fund's specialist share — the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.

Conviction exposure

20.4%

of the book in specialist-converged names

Late-stage weight

34.8%

of the book in Crowded or Fading names

Active share

94%

how far it strays from the index

The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.

Inside the book — top names by stage · as of 2026-09-09

Early Conviction
AMZN 4.8%VRT 4.6%FPS 2.3%+3 locked
Consensus
TSM 5.6%COF 4.7%PNC 4.7%+9 locked
Emerging
ICE 2.4%WAL 2.2%MDLN 1.2%
Crowded
HWM 4.1%CFR 2%LGN 1.4%
Fading
ORCL 6.4%SGRY 3.6%NXST 2.6%+7 locked

We email you the day it crosses 50% crowded, and where you stand every month.

Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.

The read · what to do with it

Support leaving these positions

ORCL 6.4% of the fund · Fading

HWM 4.1% of the fund · Crowded

SGRY 3.6% of the fund · Fading

NXST 2.6% of the fund · Fading

MDGL 2.3% of the fund · Fading

Where it's genuinely early

AMZN 4.8% of the fund · Early Conviction

VRT 4.6% of the fund · Early Conviction

ICE 2.4% of the fund · Emerging

Read from today's disclosed book. Evidence, not advice.

The evidence base updates this week.

The specialists — not the whales — are already positioned for what comes next. Stop finding out last.

Create your free account

No card required · open the feed in 30 seconds